tirzepatide gout risk How to manage in patients initiated on (Glucagon-like peptide-1 (GLP-1) receptor agonist)? Is tirzepatide (Mounjaro) safe to

Exploring how the GLP-1 function may provide benefits beyond weight loss and diabetes

Underline the necessity for a pre-dose fasting condition (enough to have an empty stomach) and observing an additional fasting period of at least 30 min post-dose, along with avoiding pharmacological interactions to allow correct semaglutide absorption

The presence of diabetes promotes the progression of simple fatty liver to non-alcoholic steatohepatitis (NASH) and cirrhosis, and the presence of NAFLD increases the risk of diabetic complications

Andrea BSN, RN - Bio Andrea Saldvar is a skilled and bilingual board-certified registered nurse with a Bachelor of Science in Nursing from Texas Tech University